The board of directors of CANbridge Pharmaceuticals Inc. announced that the principal place of business of the Company in Hong Kong will be changed to Room B01, 20/F, CITIC Tower, 1 Tim Mei Avenue, Admiralty, Hong Kong with effect from April 15, 2024. The website of the Company remain unchanged.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 HKD | -4.41% | +1.56% | -67.17% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-67.17% | 18.49M | |
+18.32% | 78.7B | |
+14.09% | 9.26B | |
-13.94% | 4.92B | |
+48.58% | 4.66B | |
+14.10% | 4.27B | |
+18.65% | 2.44B | |
-25.55% | 2.22B | |
+15.73% | 2.15B | |
-40.52% | 1.89B |
- Stock Market
- Equities
- 1228 Stock
- News CANbridge Pharmaceuticals Inc.
- CANbridge Pharmaceuticals Inc. Announces Change of Principal Place of Business in Hong Kong, Effect from April 15, 2024